MedPath

Western History Collection

Western History Collection logo
🇺🇸United States
Ownership
Private
Established
1890-01-01
Employees
10K
Market Cap
-
Website
http://www.ou.edu

Novel Hafnium-Based Treatment Trial Launches for Cisplatin-Ineligible Head and Neck Cancer Patients

International researchers launch NANORAY-312 trial investigating hafnium metal therapy combined with radiation as a novel treatment approach for head and neck cancer patients unsuitable for cisplatin treatment.

© Copyright 2025. All Rights Reserved by MedPath